Using real-world Qdata, Ocular Therapeutix was able to fulfill postmarketing regulatory requirements, which eliminated the need to conduct a 5,000+ subject post-approval rare safety outcomes study.
Verana Health Pre-Approval and Post-Approval Offerings
Postmarketing Safety Studies
Treatment Patterns and Outcomes
Use Qdata, quality real-world data (RWD), to help satisfy regulatory requirements for postmarketing safety data. Qdata is derived from exclusive, speciality electronic health care records (EHRs), so we can help you better identify adverse events that may be difficult to assess in prospective research. We can help you track early usage of your drug or device in the market while monitoring safety events to help meet FDA or other regulatory commitments.
Activate our exclusive Qdata to deeply understand treatment patterns and outcomes of your therapeutic in the real world. Qdata leverages both structured and unstructured EHR data—including physician notes—to provide a deep understanding of symptoms, diagnoses, reasons for treatment changes, side effects, and patient outcomes over time. We can help you track how your therapy is performing within select de-identified patient cohorts to inform business decisions.
Pricing and Market Access Study
Patient Journey and Patient Burden
Leverage comprehensive Qdata to understand where your patients are accessing therapies and how that compares to others in the market. We can help uncover and monitor where and how your therapy is being adopted in the real-world to inform your market access and commercial strategies.
Uncover the patient journey and burden-of-disease by leveraging longitudinal Qdata. Qdata stems from real-world data generated from more than 20,000 healthcare clinicians and more than 50 EHRs across Verana’s two registries–and is often linked with claims data to inform real-world evidence (RWE). You can gain quality insights from the breadth and depth of our exclusive datasets in ophthalmology and urology—from initial symptoms and diagnosis to treatment switching and long-term patient outcomes.
Comparative Effectiveness
Leverage Verana Health’s exclusive Qdata to answer your comparative effectiveness research questions. Analysis of Qdata can help deliver insight into which therapies work best for which patients and where the greatest benefits or potential issues may lie across patient cohorts in the real world. We can help you understand how use of your therapy in the market is measuring against other interventions to inform business strategy and decisions.
Our Customers
Verana Health is proud to collaborate with these leading Life Sciences organizations
Verana Health Supports RWE Teams Across Life Sciences
Health Economics and Outcomes Research
Medical Affairs
Data Science and Biostatistics
Verana Health supports HEOR professionals by delivering real-world evidence. We help you understand treatment patterns and outcomes for your therapy pre-approval or post-approval to inform your reimbursement or patient access strategy.
Verana Health works with Medical Affairs teams to provide a deep understanding of the patient journey, assess treatments and outcomes, as well as help satisfy regulatory requirements. We deliver insights from real-world data, so you can help bridge the gap between research and commercialization.
Verana Health supports data science, analytics and biostatistics teams with customized analyses and our curated, quality Qdata modules to bridge data gaps in your organization.
Verana Health Pre-Approval and Post-Approval Case Studies
Post-Approval Safety
One of Verana Health’s clients leveraged our exclusive, de-identified Qdata to monitor post-approval safety and commercial uptake of a marketed product. The client performed pre-and post-launch studies on drug safety and the demographic characteristics of early patients who received the drug to investigate real-world safety and treatment patterns of patients receiving the drug.
Postmarketing Safety Study
Understanding a Patient Journey
One of Verana Health’s clients wanted to study the association of disease type and clinical outcomes in areas not immediately linked to the site of the disease. Verana Health worked with the company’s researchers to create a full patient journey from multiple de-identified data sources, including Qdata and claims data, gaining key information around patient outcomes, prescription adherence, patient history, and outcomes measures.
Verana Health’s RWE By the Numbers
Life Sciences Companies are Customers
Clinicians Participate in our RWD Network
De-identified Patients Included in our RWD Network
Peer-reviewed Studies Published Using Verana Health Data
Therapeutic Areas with Numerous Diseases
Years Longitudinal Data
*Data Current To: January 2025
Verana Health’s Therapeutic Areas
Pre-Approval and Post-Approval Insights Powered by Verana Health’s Data & Technology
Exclusive real-world data network of more than 20,000 clinicians in ophthalmology and urology.
Clinician-directed and AI-enhanced population health data engine powering an advanced data integrity feedback loop.
Research-ready, disease-specific data modules to power quality insights for real-world evidence and clinical trial activation.
Advanced, clinically driven Artificial Intelligence techniques infused throughout the data process across both structured and unstructured data.
Let’s Accelerate Research Together
Interested in collaborating with Verana Health or just want to stay updated on our company happenings?
Take a minute to submit your contact information.